Leukocyte differential gene expression prognostic value for high versus low seizure frequency in temporal lobe epilepsy.

"availability of data and materials all fastq files and gene expression data have been deposited into ncbi's gene expression omnibus (geo) repository. accession# gse217726"

"Declarations Ethics approval and consent to participateAll procedures performed in studies involving human participants were in accordance with the ethical standards of the University of Arizona Institutional Review Board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.IRB# 1401194084, The University of Arizona. Informed consent to participate in the study was obtained from all participants and full documentation is able to be provided upon request. Consent for publicationAuthor M.W. personally obtained University of Arizona IRB-approved consent for all subjects. All patients we informed during the research consent process that their results, including demographic data, will be aggregated, published and available to the general public in the scientific literature, including through the Pub Med website during explanation of Subject Consent, Page 7, lines 245 & 246: “Will I hear back on any results that directly impact me?—The results of our research at UA will be available in the public domain.” Competing interestsThe authors declare that they have no competing interests. Author Dr. Weinand has been assigned the following patent application by the University of Arizona (patent ID# UA23-142) titled, “METHODS FOR THE PROGNOSIS AND TREATMENT OF TEMPORAL LOBE EPILEPSY.” for work relating to the research described in this manuscript. Dr. Weinand has received no financial compensation for the above assigned patent. Competing interests The authors declare that they have no competing interests. Author Dr. Weinand has been assigned the following patent application by the University of Arizona (patent ID# UA23-142) titled, “METHODS FOR THE PROGNOSIS AND TREATMENT OF TEMPORAL LOBE EPILEPSY.” for work relating to the research described in this manuscript. Dr. Weinand has received no financial compensation for the above assigned patent."

"Funding Weinand M, Co-PI, received support for purchase of laboratory materials and gene expression analysis from RO1MH065151 (Yuri Persidsky, Temple University) (HCS 04–42), NIH subcontract from Temple University to University of Arizona; the Department of Surgery 2016 Faculty Seed Grant, University of Arizona College of Medicine; and the 2016 University of Arizona Health Sciences Clinical Research Pilot Program Award (UAHSCRPA)."